Inflammatory and atherosclerotic interactions in the depleted uremic patient

Blood Purification

Volumn 19, Issue 1, 2001, Pages 53-61

  Stenvinkel, Peter ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Cytokines; Inflammation; Malnutrition; Soluble adhesion molecules

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; PENTOXIFYLLINE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CYTOKINE PRODUCTION; DIALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; MALNUTRITION; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; UREMIA;

EID: 0035215014     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014479     Document Type: Conference Paper

References (90)

1. Accelerated atherosclerosis in prolonged maintenance haemodialysis
2. Cardiovascular risk factors in chronic renal failure and hemodialysis populations
3. Clinical epidemiology of cardiovascular disease in chronic renal failure
4. Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure
5. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
6. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients
7. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
8. C-reactive protein as a cardiovascular risk factor. More than an epiphenomenon
9. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
10. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients
11. Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients
12. High serum hyaluronan indicates poor survival in renal replacement therapy
13. Factors influencing malnutrition in hemodialysis patients. A cross-sectional study
14. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare?
15. Malnutrition in dialysis: Malnourishment or uremic inflammatory response?
16. Relationship between nutritional status and the glomerular filtration rate: Results from the MDRD Study
17. Malnutrition as a main factor in morbidity and mortality of hemodialysis patients
18. Biological basis of hypoalbuminemia in ESRD
19. Serum albumin distribution in early treated anorexia nervosa
20. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
21. Predictors of survival in continuous ambulatory peritoneal dialysis patients: A five year prospective study
22. Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima media-media thickness
23. Apolipoprotein A, fibrinogen, age, and a history of stroke are predictors of death in dialyzed diabetic pateints: A prospective study in 412 subjects
24. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival
25. Determinants of albumin concentration in hemodialysis patients
26. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin and peritoneal dialysis patients
27. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA-syndrome)
28. C-reactive protein and outcome after ischemic stroke
29. Association of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
30. Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients
31. Serum C-reactive (CRP) and risk of death in chronic dialysis patients
32. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study
33. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients
34. C-reactive protein and atherosclerosis in dialysis patients
35. C-reactive protein as an outcome predictor for maintenance hemodialysis patients
36. The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients
37. Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure?
38. Examination of the relation between peridontal health status and cardiovascular risk factors: Serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen
39. Immunologic function and survival in hemodialysis patients
40. Plasma levels of IL-1b, TNF-α and their specific inhibitors in un-dialyzed chronic renal failure, CAPD and hemodialysis patients
41. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
42. TNF-α:mRNA, plasma protein levels and soluble receptors in patients with chronic hemodialysis, on CAPD and with end-stage renal failure
43. Malnutrition, cardiac disease and mortality - An integrated point of view
44. Influence of co-morbidity on mortality and morbidity of hemodialysis patients
45. Effect of increasing serum albumin on plasma D-dimer, von Willebrand factor, and platelet aggregation in CAPD patients
46. Plasma concentrations of C-reactive protein is increased in type 1 diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: Evidence for chronic inflammation
47. Elevated serum levels of soluble adhesion molecules predict death in predialysis patients: Association with malnutrition, inflammation and cardiovascular disease
48. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo
49. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease
50. Cytokines and anorexia: A brief overview
51. Geriatric cachexia: The role of cytokines
52. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients
53. Cytokine production and nutritional status in hemodialysis patients
54. Endotoxin and cytokines induce expression of leptin, the ob gene product in hamsters. A role for leptin in the anorexia of infection
55. Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia
56. Increased leptin expression in mice with bacterial peritonitis is partially regulated by tumor necrosis factor alpha
57. Cytokines, muscle proteolysis, and the catabolic response to infection and inflammation
58. Administration of endotoxin, tumour necrosis factor, or interleukin-1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase
59. Outcome and risk factors for left ventricular disorders in chronic uremia
60. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
61. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
62. Wasting as independent risk factor for mortality in chronic heart failure
63. Endothelial expression of a mononuclear leucocyte adhesion molecule during atherogenesis
64. Molecular bases of the acute coronary syndromes
65. Circulating adhesion molecules in disease
66. Plasma concentrations of soluble intercellular adhesion molecule-1 and risk of future myocardial infarction in apparently healthy men
67. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
68. Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis
69. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients
70. Cytokines and endothelial cell biology
71. Fibrin as a factor in atherogenesis
72. Cardiovascular disease, fibrinogen and the acute phase response. Associations with lipids and blood pressure in patients with chronic renal disease
73. Elevated lipoprotein (a) and fibrinogen levels increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients
74. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age
75. Apo(a) isoform size, nutritional status and inflammatory markers in chronic renal failure
76. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients
77. High lipoprotein(a) levels in chronic hemodialysis patients are closely related to acute phase reaction
78. Genetic influence on lipoprotein(a) concentration
79. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
80. Complement and atherogenesis: The unknown connection
81. The rationale for healthy start dialysis
82. Cytokine production in haemodialysis
83. Increase of C-reactive protein serum values following haemodialysis
84. Effect of the hemodialysis membrane on the inflammatory reaction in vivo
85. Role of different dialysis membranes in the release of interleukin-6 soluble receptor in uremic patients
86. Progression of coronary atherosclerosis is accelerated in hemodialysed (HD) patients than chronic renal insufficiency (CRI) patients
87. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis
88. Effects of thalidomide on HIV-associated wasting syndrome: A randomized, double blind, placebo-controlled clinical study
89. Thalidomide treatment reduces tumour necrosis factor-α production and enhances weight gain in patients with pulmonary tuberculosis